spartalizumab

E1995669 UNEXPLORED

Spartalizumab is an investigational humanized monoclonal antibody that blocks the PD-1 immune checkpoint to enhance anti-tumor immune responses in cancer therapy.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
spartalizumab canonical	2

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

programmed cell death protein 1 → targetOfDrug → spartalizumab ⓘ

PD-1 → isTargetOfDrug → spartalizumab ⓘ